Answers are grounded in this paper and cite their sources.
Preclinical studies demonstrate that G9a inhibitors reduce alcohol consumption in mice, suggesting new treatment options for alcohol use disorder.
Together, our studies suggest that G9a inhibitors could be effective, safe, and novel AUD therapeutics that reduce stress and dependence-related high levels of alcohol drinking in AUD patients.
No takes yet. Share an insight, caveat, or question.
Holmes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: